AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MEDICAL
Merck pulls plans for Medco IPO
The Merck unit cited market conditions. It had planned to raise $934 mil to $1.03 bil by selling 46.7 mil shares for $20-$22 each. But the IPO had been delayed three times amid market woes and accounting questions at the pharmacy benefits manager unit. Merck still expects a Medco IPO within 12 months.
AmerisourceBergen Q3 profit up
Merger savings helped boost the drug distributor's profit 48% to 86 cents a share, a nickel over views. But some investors hoped for 87 cents. AmerisourceBergen's sales rose 230% to $11.6 bil. Amerisource expects to beat Q4 and full-year views. It's the third time Amerisource upped '02 targets. But its shares fell 4%.
Elan Q2 profit fell 84%, to ax jobs
The Irish drug firm earned 7 cents a share, well below views of 22 cents. Including charges, Elan lost $2.29. Revenue slipped 1% to $456.1 mil. Elan plans to cut about 1,000 jobs, or 21% of its staff, by year-end. The scandal-hit firm also hopes to raise $1 bil in the next nine months by selling off its noncore businesses.